• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续53例使用心肺支持的经验与指导

Experience and directions using cardiopulmonary support in fifty-three consecutive cases.

作者信息

Moore C H, Rubin J M, Schnitzler R N, Canon D S, Arpin D

机构信息

Humana Hospital, San Antonio, Texas.

出版信息

ASAIO Trans. 1991 Jul-Sep;37(3):M340-2.

PMID:1751177
Abstract

Emergency cardiopulmonary support (CPS) was instituted in 53 consecutive patients for acute life threatening pathologies. Indications for CPS deployment were: cardiac arrest, 60% (n = 32); cardiogenic shock, 20.4% (n = 11), supported angioplasty, 13% (n = 7); and adult respiratory distress syndrome, 5.6% (n = 3). Cardiopulmonary support was successfully deployed in 51 of the 53 patients (96%), resulting in a mean blood pressure greater than or equal to 60 mmHg, CO greater than or equal to 3-5 L/min, and partial pressure of oxygen greater than or equal to 100 mmHg, with venous oxygen saturation greater than or equal to 60%. The average time from arrest to CPS deployment was 40 minutes. Seventy-nine major cardiovascular procedures were done in these 51 patients (average, 1.5/patient). The duration of support ranged from 1 to 75 hrs (mean, 16.1 hrs). Twenty-seven patients (53%) were weaned, 13 successfully (32%), with 11 (85%) surviving greater than 24 hrs, and six (46%), greater than 30 days. The other 24 patients (47%) were transferred to other treatment modalities, including cardiac surgery and bridge-to-transplant ventricular assist devices. Four of these patients died (17%), whereas 20 (83%) survived. Of these survivors, 19 (95%) survived greater than 24 hrs, whereas 11 (55%) survived greater than 30 days. The overall survival using the CPS system is 59% short-term (greater than 24 hrs.), and 33% long-term (greater than 30 days). In conclusion, the CPS system is a potent and effective resuscitative tool. It requires transfer to other treatment modalities for survival in most cases.

摘要

对53例患有急性危及生命病症的患者连续实施了紧急心肺支持(CPS)。实施CPS的指征如下:心脏骤停,60%(n = 32);心源性休克,20.4%(n = 11);支持性血管成形术,13%(n = 7);以及成人呼吸窘迫综合征,5.6%(n = 3)。53例患者中有51例(96%)成功实施了心肺支持,使平均血压大于或等于60 mmHg,心输出量大于或等于3 - 5 L/分钟,氧分压大于或等于100 mmHg,静脉血氧饱和度大于或等于60%。从心脏骤停到实施CPS的平均时间为40分钟。这51例患者共进行了79项主要心血管手术(平均每人1.5项)。支持时间为1至75小时(平均16.1小时)。27例患者(53%)撤机,13例成功撤机(32%),其中11例(85%)存活超过24小时,6例(46%)存活超过30天。另外24例患者(47%)转至其他治疗方式,包括心脏手术和桥接至移植的心室辅助装置。这些患者中有4例死亡(17%),20例(83%)存活。在这些存活者中,19例(95%)存活超过24小时,11例(55%)存活超过30天。使用CPS系统的总体短期存活率(超过24小时)为59%,长期存活率(超过30天)为33%。总之,CPS系统是一种强大且有效的复苏工具。在大多数情况下,患者需要转至其他治疗方式以实现存活。

相似文献

1
Experience and directions using cardiopulmonary support in fifty-three consecutive cases.连续53例使用心肺支持的经验与指导
ASAIO Trans. 1991 Jul-Sep;37(3):M340-2.
2
Percutaneous cardiopulmonary support in cardiac arrest.
ASAIO Trans. 1991 Jul-Sep;37(3):M282-3.
3
A 20-year experience with urgent percutaneous cardiopulmonary bypass for salvage of potential survivors of refractory cardiovascular collapse.20 年紧急经皮心肺旁路术抢救难治性心血管衰竭潜在幸存者的经验。
J Thorac Cardiovasc Surg. 2010 Mar;139(3):753-7.e1-2. doi: 10.1016/j.jtcvs.2009.11.018.
4
Mechanical cardiopulmonary support for refractory cardiogenic shock.用于难治性心源性休克的机械心肺支持
Heart Lung. 1990 Sep;19(5 Pt 1):514-23.
5
[Emergency percutaneous cardiopulmonary support for patients with cardiac arrest or severe cardiogenic shock].[心脏骤停或严重心源性休克患者的急诊经皮心肺支持]
Nihon Kyobu Geka Gakkai Zasshi. 1996 Nov;44(11):2006-10.
6
Emergency cardiopulmonary bypass support in patients with cardiac arrest.心脏骤停患者的紧急体外循环支持
J Thorac Cardiovasc Surg. 1991 Mar;101(3):450-4.
7
Cardiac resuscitation with percutaneous cardiopulmonary support.
Lancet. 1992 Aug 29;340(8818):513-4. doi: 10.1016/0140-6736(92)91711-g.
8
Experience with percutaneous venoarterial cardiopulmonary bypass for emergency circulatory support.经皮静脉-动脉体外膜肺氧合用于紧急循环支持的经验。
Crit Care Med. 2003 Mar;31(3):758-64. doi: 10.1097/01.CCM.0000053522.55711.E3.
9
Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest.高危经皮冠状动脉介入治疗、难治性心源性休克及实验室内心脏骤停期间经皮生命支持的疗效与安全性。
J Invasive Cardiol. 2011 Apr;23(4):141-7.
10
Resuscitation of non-postcardiotomy cardiogenic shock or cardiac arrest with extracorporeal life support: the role of bridging to intervention.体外生命支持复苏非心脏手术后心源性休克或心搏骤停:桥接介入治疗的作用。
Resuscitation. 2012 Aug;83(8):976-81. doi: 10.1016/j.resuscitation.2012.01.010. Epub 2012 Jan 21.

引用本文的文献

1
Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice.急性心肌梗死并发心源性休克的管理:迈向循证医疗实践
Heart. 2000 Jun;83(6):621-6. doi: 10.1136/heart.83.6.621.